A drug recently approved to prevent migraine may start working right away, according to a new study. The study looked at the drug atogepant, which is a calcitonin gene-related peptide (CGRP) receptor antagonist taken by mouth.
from Top Health News -- ScienceDaily https://ift.tt/FBxV7DL
the news of the day, for today, top news of today, world news today live, top local news, top news stories of the day, top news today in the world, news today nyc, top news today local,
Subscribe to:
Post Comments (Atom)
Researchers followed 400,000 kids for 20 years and found a lasting pre-K advantage
A 20-year study of 400,000 students found that children who attended public school pre-K earned better grades and test scores through high s...
-
from Yahoo News - Latest News & Headlines https://ift.tt/3F3zLk8
-
from Yahoo News - Latest News & Headlines https://ift.tt/VDTlZbk
-
Two of the traits that set modern humans apart from non-human primates are taller stature and a higher basal metabolic rate. Researchers hav...
No comments:
Post a Comment